Evidence map›Paper›PMID 41648602›Full record

ArticlebioRxiv : the preprint server for biology2026

Amplified genome editing by

Wayne Ngo, Daniel Rosas-Rivera, Kevin M Wasko, Longhui Qiu, Min Hyung Kang, Shaan Gogna, Jingkun Zeng, Mason T Hooks, Jamie L Y Wu, Zhongmei Li and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wayne NgoInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.ORCID 0000-0002-5755-2303
Daniel Rosas-RiveraInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Kevin M WaskoInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Longhui QiuDepartment of Medicine, University of California, San Francisco; San Francisco, CA, USA.
Min Hyung KangInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Shaan GognaInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Jingkun ZengInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Mason T HooksInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Jamie L Y WuInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.
Zhongmei LiGladstone-UCSF Institute of Genomic Immunology; San Francisco, CA, USA.
Jennifer A DoudnaInnovative Genomics Institute; University of California, Berkeley; Berkeley CA, USA.ORCID 0000-0001-9161-999X

Funding

Project 3U54AI170792 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDREJ SALI · 2022 to 2026
$35.7M
RESEARCH PROJECT 2U19AI135990 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDREJ SALI · 2018 to 2026
$21.4M
Resource Core II: In Vivo CoreU19NS132303 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI NIREN MURTHY · 2023 to 2026
$19.7M
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systemsU01AI142817 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BANFIELD, JILLIAN, DOUDNA, JENNIFER A · 2018 to 2022
$2.0M
Cas9 RNP delivery to immune cells in vivo via molecular targetingUH3AI150552 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI DOUDNA, JENNIFER A, WILSON, ROSS C · 2022 to 2022
$1.3M
BD FACSAria II Flow CytometerS10RR028962 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI CAVROIS, MARIELLE · 2011 to 2011
$544k
Targeted Delivery of Cas9 to Lung Epithelial Cells using Enveloped Delivery VehiclesR21HL173710 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI DOUDNA, JENNIFER A · 2024 to 2025
$520k
NCRR NIH HHS S10 RR028962NHLBI NIH HHS R21 HL173710NIAID NIH HHS U01 AI142817NIAID NIH HHS U19 AI135990NIAID NIH HHS U54 AI170792NIAID NIH HHS UH3 AI150552NINDS NIH HHS U19 NS132303
6 · The paper itself

Abstract

Genome editing enzymes have vast therapeutic potential. However, achieving sufficient delivery

Identifiers

PMID41648602
PMCPMC12871335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.